Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features
Maximilian Y Deng, Martin Sill, Jason Chiang, Jens Schittenhelm, Martin Ebinger, Martin U Schuhmann, Camelia-Maria Monoranu, Till Milde, Andrea Wittmann, Christian Hartmann, Clemens Sommer, Werner Paulus, Jutta Gaertner, Wolfgang Brueck, Thomas Ruediger, Alfred Leipold, Zane Jaunmuktane, Sebastian Brandner, Felice Giangaspero, Paolo Nozza Show all
Acta Neuropathologica | SPRINGER | Published : 2018
This work was supported by the Everest Centre for Low-grade Paediatric Brain Tumours (The Brain Tumour Charity, UK), A Kids' Brain Tumor Cure (PLGA) Foundation, the German Cancer Consortium (DKTK), and fellowships from the Mildred-Scheel doctoral program of the German Cancer Aid and the German National Academic Foundation (to M.Y.D.). Sebastian Brandner was partially supported by the National Institute of Health Research (NIHR) UCLH/UCL Biomedical Research Centre. For excellent technical support and expertise we sincerely thank the Microarray Unit of the German Cancer Research Center (DKFZ) Genomics and Proteomics Core Facility, and Hai-Yen Nguyen and Laura Doerner (Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg).